Shares of WW International Inc. plunged Wednesday after the health and wellness company known as WeightWatchers filed for bankruptcy, facing a mounting debt burden that offering weight-loss drugs ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Medically reviewed by Femi Aremu, PharmD Ozempic and Wegovy are both glucagon-like peptide-1 (GLP-1) receptor agonists and ...

In an exclusive interview with TODAY, WeightWatchers CEO Tara Comonte broke down what this news means for the company's 3.4 ...

Ozempic and other drugs like it have been threatening the more traditional weight loss industry since they premiered — and it ...

People with type 2 diabetes using GLP-1s had a lower risk for colorectal cancer than those undergoing bariatric surgery, as well as the general population.

GLP-1 receptor agonists remain blockbuster drugs for weight management for people with overweight or obesity. Increasingly, ...

WeightWatchers, known for its diet programs once endorsed by celebrities including Oprah Winfrey, has filed for bankruptcy after struggling to compete with drugs like Ozempic.

A YOUNG mum has shared a raw account of the hidden dangers of weight loss jabs after her body began shutting down. Miranda ...

WeightWatchers, known for its diet programs once endorsed by celebrities including Oprah Winfrey, has filed for bankruptcy after struggling to compete with drugs like Ozempic.

Cencora raised its 2025 earnings forecast after a strong Q2 driven by U.S. drug sales, though total revenue of $75.5 billion ...

WeightWatchers, known for its diet programs once endorsed by celebrities including Oprah Winfrey, has filed for bankruptcy ...